首页|基于网络药理学及分子对接探讨半枝莲半边莲药对治疗肺癌的作用机制

基于网络药理学及分子对接探讨半枝莲半边莲药对治疗肺癌的作用机制

扫码查看
本研究旨在运用网络药理学、分子对接及动物试验,探寻半枝莲-半边莲药对治疗肺癌的作用机制。本研究运用TCMSP平台查询半枝莲-半边莲药对的化合物成分,使用Cytoscape3。7。2软件绘制成分-靶点网络图。利用GeneCards和OMIM数据库查询肺癌靶点,通过相互作用数据库平台STRING进行靶蛋白互作分析。构建核心活性成分、核心靶点与关键通路相互作用关系图,并对核心活性成分与靶点进行分子对接。雄性SD大鼠随机分为空白组、模型组、中药组(6。3g/kg),每组6只,采用气管内灌注致癌碘化油溶液法建立肺癌大鼠模型,并采用病理学检查验证造模是否成功;采用Western blot检测肿瘤组织中p-PI3K,p-Akt,EGFR和IL-6蛋白的表达情况。结果分析显示,有效活性成分及其对应靶点分别为44个、108个,主要有效活性成分为Quercetin,Kaempferol,Lu-teolin,Wogonin,Baicalein等。共筛选出肺癌靶点2 057个,Venny图显示二者交集靶点74个。PPI网络分析度值较高的靶蛋白为IL-6,EGFR,CASP3,ESR1,MYC,VEGFA,CCND1,MAPK8。GO分析显示,富集于多个生物过程、分子功能及细胞组分。KEGG信号通路分析显示主要富集在TNF信号通路,PI3K-Akt信号通路,p53信号通路等通路。成分-靶点-通路网络图显示,半枝莲-半边莲药对可能由 Quercetin,Kaempferol,Luteolin,Wogonin,Baicalein 等活性成分组成,通过作用于 IL-6,EGFR,CCND1,MYC,VEGFA,MAPK8等靶蛋白,调节PI3K-AKT信号通路,MAPK信号通路等来发挥治疗肺癌作用。分子对接结果显示,IL-6与槲皮素,EGFR、MYC、CCND1与汉黄芩素有良好的结合能力。Western blot结果表明,相较于模型组,中药组中大鼠瘤组织中p-PI3K、p-Akt、EGFR和IL-6蛋白表达均明显下降(P<0。05)。半枝莲-半边莲药对对肺癌的治疗作用是通过多种活性成分,多个靶点,多途径来实现的,本研究为今后进行深入的机制研究提供了理论依据。
Exploring the Mechanism of Scutellaria Barbata-Lonelia in the Treatment of Lung Cancer Based on Network Pharmacology and Molecular Docking
Exploring the Mechanism of Action of Scutellaria barbata-Lobelia in treating lung cancer through network pharmacology,mol-ecular docking,and animal experiments.The TCMSP platform was used to query the compounds of Scutellaria barbata-Lobelia pairs,and Cytoscape 3.7.2 software was used to draw the component-target network diagrams.GeneCards and OMIM databases were used to query the lung cancer targets,and STRING,the interaction database platform,was used to analyze the interactions between target proteins.Con-struct a diagram of the interaction between core active ingredients,core targets,and key pathways,and perform molecular docking between core active ingredients and targets.Male SD rats were randomly divided into a blank group,a model group,and a traditional Chinese medi-cine group(6.3g/kg),with 6 rats in each group.A lung cancer rat model was established by intratracheal infusion of carcinogenic iodized oil solution.Pathological examination to verify whether the modeling was successful;western blot was used to detect the expression of p-PI3K,p-Akt,EGFR,and IL-6 proteins in tumor tissue.Analysis shows that there are 44 active ingredients and 108 corresponding targets,respectively,and the main effective active ingredients were quercetin,kaempferol,luteolin,wogonin,baicalein and so on.A total of 2,057 lung cancer targets were identified,and the Venny diagram showed 74 intersecting targets.The target proteins with higher values in PPI net-work,which were IL-6,EGFR,CASP3,ESRI,MYC,VEGFA,CCND1,MAPK8.GO analysis showed that it is mainly enriched in multiple biological processes,molecular functions,and cellular components.The analysis of KEGG signaling pathway showed that it was mainly en-riched in TNF signaling pathway,PI3K-Akt signaling pathway,p53 signaling pathway and other pathways.The component-target-pathway network diagram shows that the Scutellaria barbata-Lobelia pairs may be composed of quercetin,kaempferol,luteolin,wogonin,baicalein,etc.,which exert their therapeutic effects by acting on target proteins,such as IL-6,EGFR,CCND1,MYC,VEGFA,MAPK8,etc.,as well as by regulating the pathways such as PI3K-AKT signaling pathway,MAPK signaling pathway and so on.Which play a therapeutic role in lung cancer.The molecular docking results showed that IL-6 had a good binding ability with quercetin,and EGFR,MYC,and CCND1 had a good binding ability with baicalein.Western blot results showed that compared with the model group,the expression of p-PI3K,p-Akt,EGFR,and IL-6 proteins in the tumor tissues of the rats in the traditional Chinese medicine group were significantly decreased(P<0.05).The Scutellaria barbata-Lobelia medicinal pair can exert therapeutic effects on lung cancer through multiple active ingredients,multiple tar-gets and multiple pathways,this study provides a theoretical basis for further in-depth mechanism research in the future.

Network pharmacologyScutellaria barbata-Lobelialung cancerPI3K-Akt signaling pathway

庞雪莹、赵欣华、韩笑、张俐佳、刘业、王业伟

展开 >

黑龙江中医药大学附属第一医院,黑龙江 哈尔滨 150040

哈尔滨医科大学附属肿瘤医院,黑龙江 哈尔滨 150080

网络药理学 半枝莲-半边莲 肺癌 PI3K-Akt信号通路

中国博士后科学基金"地区专项支持计划"项目黑龙江省中医药局项目黑龙江省中医药局项目

2002MD713752ZHY2020-099ZHY18-059

2024

特产研究
中国农业科学院特产研究所,中国农学会特产学会

特产研究

CSTPCD
影响因子:0.331
ISSN:1001-4721
年,卷(期):2024.46(3)
  • 41